Biomarker Imaging


Förderkennzeichen

81Z6600262

Projektnummer

513

Institution
Klinikum der Universität München
Projektleiter
Reiser
Standort
München
Kurzbeschreibung

Biomarker Imaging develops diagnostic, prognostic and predictive CT and MRI biomarkers for heart disease and establishes them in clinical routine. This includes:

• Validation and … 

Biomarker Imaging develops diagnostic, prognostic and predictive CT and MRI biomarkers for heart disease and establishes them in clinical routine. This includes:

• Validation and standardization of recording and evaluation techniques of 4D flow MRI in children • Characterization of diffuse myocardial fibrosis in hereditary cardiomyopathy using pre- and post-contrast T1-mapping • Contrast dose optimization in CT angiography for determining the size of the aortic annulus before TAVI • Evaluation of non-invasive imaging methods without radiation exposure for primary diagnostic imaging and assessment of large vessel vasculitis • Evaluation of the effect of obstructive sleep apnea syndrome (OSAS) on cardiac function as determined by MRI

Projektart
Standortprojekt
Stichwörter
MRI, CT, 4D-flow MRI, T1-mapping, large vessel vasculitis, 3D-Blackblood, OSAS, TAVI
Topic
imaging
Fördersumme
€ 689.563,18
Beginn
15.10.2011
Ende
31.12.2018